Considerations of CD8+ T Cells for Optimized Vaccine Strategies Against Respiratory Viruses
The primary goal of vaccines that protect against respiratory viruses appears to be the induction of neutralizing antibodies for a long period. Although this goal need not be changed, recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have drawn strong attention to another...
Main Authors: | Toshiro Hirai, Yasuo Yoshioka |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.918611/full |
Similar Items
-
Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia
by: Eigo Kawahara, et al.
Published: (2023-12-01) -
A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
by: Nagisa Tokunoh, et al.
Published: (2023-08-01) -
Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination
by: Takuto Nogimori, et al.
Published: (2023-01-01) -
Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
by: Kaitlyn M. Morabito, et al.
Published: (2018-08-01) -
Vaccine induced memory CD8+ T cells efficiently prevent viral transmission from the respiratory tract
by: Jinglin Zhou, et al.
Published: (2023-12-01)